Corporate Governance
View other leadership profiles by:

Leadership Team

Michael Hencke is Head of Investor Relations at Biogen.

Mr. Hencke joined Biogen in 2012 as a member of the Company’s U.S. commercial organization contributing to the launch of TECFIDERA. He joined Biogen’s Investor Relations team in 2014 and has extensive experience covering all aspects of Biogen’s commercial business and pipeline. Prior to joining Biogen, Mr. Hencke co-founded Semprus BioSciences, a medical device spin-out from the Massachusetts Institute of Technology (M.I.T.), and was previously an Analyst at Health Advances, a strategy consulting firm focused on the healthcare industry.  

Mr. Hencke received a Bachelor of Science in Chemical Engineering from M.I.T. and an M.B.A. from Harvard Business School.

Other Leadership Profiles